CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
103.33
+0.88 (0.86%)
Feb 17, 2026, 9:30 AM EST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $52.01 billion as of February 18, 2026. Its market cap has decreased by -37.36% in one year.
Market Cap
52.01B
Enterprise Value
64.51B
Revenue
15.41B
Ranking
n/a
PE Ratio
37.26
Stock Price
$103.33
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 52.01B, an increase of 22,497.47%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 52.02B | -6.32% |
| Dec 31, 2025 | 55.52B | -34.20% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 383.25M |
| CytoDyn | 308.63M |
| Silence Therapeutics | 210.19M |
| HST Global | 139.70M |
| Vaxart | 135.83M |
| BioStem Technologies | 97.44M |
| Nuo Therapeutics | 77.26M |
| Vicapsys Life Sciences | 48.56M |